Could RNA Therapy Preserve Lean Muscle and Boost Fat Loss During GLP-1 Treatment?
The combination cut lean-mass loss to about 5.5%, compared with about 10% for semaglutide alone, while improving glucose tolerance in mice.
6 Articles
6 Articles
Some people suffer setbacks after using weight loss medication, losing muscle along with fat. Rapid muscle loss makes one more susceptible to illness and slows down recovery. Scientists have opened a path to prevent muscle loss by using a method that promotes fat burning simultaneously with the use of weight loss drugs. A research team led by Professor Joseph Bass of Northwestern University School of Medicine stated, “RNA therapy [is similar to]…
Naiarabrocal Endocrinology In 'PNAS' GLP-1 drugs have transformed the treatment of obesity thanks to their ability to achieve significant weight reductions. However, part of this loss corresponds to lean mass and not just fat. In addition, after discontinuation of treatment, weight recovery can occur, mainly at the expense of fat tissue.A new preclinical study of researchers from Northwestern University, in the United States, explores a possible…
Dramatic Breakthrough: The RNA Therapy That Could Revolutionize Semaglutide Weight Loss
“`html Alright, let’s talk about something truly fascinating that’s shaking up the world of weight loss. If you’ve been following the health and wellness space, you’ve undoubtedly heard of semaglutide, the GLP-1 receptor agonist that’s become a household name for its incredible efficacy in helping people shed pounds. But what if I told you there’s a new kid on the block, an RNA therapy, that promises to supercharge semaglutide’s effects while ta…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
